Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Modified Smartphone-based System Automatically Determines Antibiotic Resistance

By LabMedica International staff writers
Posted on 27 Dec 2016
Microbiology researchers have described a modified smartphone that functions as an automated diagnostic test reader for the determination of antimicrobial resistance.

Routine antimicrobial susceptibility testing (AST) can prevent deaths due to bacteria and reduce the spread of multi-drug-resistance, but cannot be regularly performed in resource-limited-settings due to technological challenges, high-costs, and lack of trained professionals.

A team of investigators at the University of California, Los Angeles (USA) has reported the development of a cellphone-based 96-well microtiter-plate (MTP) reader, capable of performing AST without the need for trained diagnosticians.

The proposed system includes a three dimensional-printed smartphone attachment that holds and illuminates the MTP using a light-emitting-diode array. More...
An inexpensive optical fiber-array enables the capture of the transmitted light of each well through the smartphone camera. A custom-designed application sends the captured image to a server to automatically determine well turbidity, with results returned to the smartphone in about one minute.

The investigators tested this mobile-reader on clinical isolates of Klebsiella pneumoniae containing highly resistant antimicrobial profiles using MTPs prepared with 17 antibiotics targeting Gram-negative bacteria. Using 78 patient isolate test-plates, they demonstrated that the mobile-reader met the [U.S.] Food and Drug Administration-defined AST criteria, with a well-turbidity detection accuracy of 98.21%, minimum-inhibitory-concentration accuracy of 95.12%, and a drug-susceptibility interpretation accuracy of 99.23%, with no very major errors.

"This work is extremely important and timely, given that drug-resistant bacteria are increasingly becoming a global threat rendering many of our first-line antibiotics ineffective," said senior author Dr. Aydogan Ozcan, professor of electrical engineering and bioengineering at the University of California, Los Angeles. "Our new smartphone-based technology can help put laboratory-quality testing into much wider adoption, especially in resource-limited regions."

The smartphone AST system was described in the December 15, 2016, online edition of the journal Scientific Reports.

Related Links:
University of California, Los Angeles


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.